William Blair Expects Reduced Earnings for Procter & Gamble

The Procter & Gamble Company (NYSE:PG) – Equities researchers at William Blair decreased their Q3 2025 EPS estimates for shares of Procter & Gamble in a research report issued to clients and investors on Monday, November 25th. William Blair analyst J. Andersen now anticipates that the company will post earnings of $1.61 per share for the quarter, down from their previous estimate of $1.62. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.96 per share.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter last year, the firm earned $1.83 EPS.

PG has been the topic of a number of other research reports. Wells Fargo & Company lifted their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. DA Davidson upgraded shares of Procter & Gamble from a “neutral” rating to a “buy” rating and raised their target price for the company from $160.00 to $209.00 in a research note on Monday. Evercore ISI raised their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Finally, Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a research note on Monday, September 30th. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $180.45.

Procter & Gamble Price Performance

PG opened at $179.34 on Tuesday. The firm has a market capitalization of $422.35 billion, a PE ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The business’s 50-day moving average is $170.22 and its two-hundred day moving average is $168.90. Procter & Gamble has a 1 year low of $142.50 and a 1 year high of $180.43.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.24%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insider Buying and Selling

In related news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the transaction, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,233 shares of company stock valued at $6,024,234 over the last 90 days. Insiders own 0.18% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC increased its holdings in Procter & Gamble by 4.5% in the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after buying an additional 4,035 shares in the last quarter. Radnor Capital Management LLC purchased a new position in Procter & Gamble in the third quarter valued at $5,705,000. Welch Group LLC increased its holdings in Procter & Gamble by 0.9% in the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after buying an additional 2,990 shares in the last quarter. Swiss National Bank increased its holdings in Procter & Gamble by 0.6% in the third quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock valued at $1,213,403,000 after buying an additional 39,000 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after buying an additional 10,777 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.